Advanced search×

Pathogen yield and antimicrobial resistance patterns of chronic rhinosinusitis patients presenting to a tertiary rhinology centre.

J Otolaryngol Head Neck Surg 40(3):232-7 (2011) PMID 21518646

To examine the yield and resistance profile of pathogens in chronic rhinosinusitis (CRS) patients receiving culture-directed management and to pay particular attention to the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in this population. Retrospective review of a CRS microbiology database. Consecutive CRS patients seen at the St. Paul's Sinus Centre between June 2007 and August 2008. Canadian tertiary sinus centre. To determine the pathogens isolated, the frequency of these pathogens, and their resistance profiles. The most common bacterial pathogens isolated were Staphylococcus aureus, accounting for 39% of cultured samples, followed by Haemophilus influenzae (29%), Pseudomonas aeruginosa (15%), Streptococcus pneumoniae (12%), and Moraxella catarrhalis (11%). Only three cases of MRSA were found, one in a patient with cystic fibrosis. MRSA does not appear to pose a significant risk of morbidity in our patient population. However, ongoing concern regarding the increasing prevalence of S. aureus and antimicrobial resistance in chronic sinonasal disease highlights the importance of using culture-directed antimicrobial therapy with the goal of minimizing future resistance patterns.

Version: za2963e q8za9 q8zbb q8zc6 q8zd8 q8ze6 q8zf4 q8zg9

Similar articles you may find interesting…

  1. Cellular self-defense: how cell-autonomous immunity protects against pathogens.

    Science 340(6133):701-6 (2013) PMID 23661752

    We discuss the organizing principles that govern cellular self-defense and how intracellular compartmentalization has shaped its activities to provide effective protection against a wide variety of microbial pathogens....
  2. THE FETAL SAFETY OF MACROLIDES.

    Antimicrob Agents Chemother (2013) PMID 23650169

    Use of macrolides in the first trimester of pregnancy is not associated with an increased risk of major malformations. Exposure in the third trimester is not likely to increase neonatal risks for pyloric stenosis or intussusception in a clinically meaningful manner....
  3. Colistin is relatively safe in hematological malignancies and hematopoietic stem cell transplantation patients.

    Infection (2013) PMID 23653428

    Treatment with intravenous colistin, with dosage adjusted to renal function, was relatively safe for HM/HSCT patients, even with concomitantly administered nephrotoxic medications. Concern about nephrotoxicity should not justify a delay in initiating empirical colistin treatment in situations where...